| Net Cash Provided by (Used in) Operating Activities |
$-130,676 |
USD |
69% |
Q2 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$120,000 |
USD |
|
Q2 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
16,595,211 |
shares |
2.9% |
Q3 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$-11,741 |
USD |
97% |
Q2 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$35,518 |
USD |
-70.85% |
Q3 2025 |
Q2 2025 |
| Deferred Tax Assets, Valuation Allowance |
$254,000 |
USD |
21% |
Q1 2025 |
FY 2025 |
| Depreciation |
$7,270 |
USD |
-12.12% |
Q3 2025 |
Q2 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$-466,520 |
USD |
46% |
Q3 2025 |
Q2 2025 |
| Property, Plant and Equipment, Gross |
$261,945 |
USD |
0.16% |
Q3 2025 |
Q2 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$254,000 |
USD |
21% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q2 2025 |
| Additional Paid in Capital |
$1,646,037 |
USD |
35% |
Q3 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q2 2025 |
| Interest Expense |
$43,340 |
USD |
30% |
Q3 2025 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q2 2025 |